US Patent Issued to OCULAR THERAPEUTIX on July 15 for "Ocular implant containing a tyrosine kinase inhibitor" (Massachusetts, New Hampshire Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,565, issued on July 15, was assigned to OCULAR THERAPEUTIX INC. (Bedford, Mass.).

"Ocular implant containing a tyrosine kinase inhibitor" was invented by Charles D. Blizzard (Nashua, N.H.), Arthur Driscoll (Reading, Mass.), Rami El-Hayek (Norwood, Mass.), Michael Goldstein (Cambridge, Mass.), Joseph Iacona (Somerville, Mass.), Peter Jarrett (Burlington, Mass.), Timothy S. Jarrett (Boston), Erica Kahn (Cambridge, Mass.) and Zachary Lattrell (Newburyport, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the t...